Rockwell Medical (RMTI) Free Cash Flow Growth (3y) (2013 - 2026)
Rockwell Medical (RMTI) Free Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn | 14.41% |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn | 216.31% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 4.08% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 49.44% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -10.40% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | -9.38% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 134.18% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Rockwell Medical | 29.69 Mn | 4.89 Mn | 3.24 Mn | 41.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.31% |
| Mar 31, 2026 | 46.23% |
| Dec 31, 2025 | 95.80% |
| Sep 30, 2025 | -15.61% |
| Jun 30, 2025 | 31.80% |
| Mar 31, 2025 | 28.81% |
| Dec 31, 2024 | 27.06% |
| Sep 30, 2024 | 36.92% |
| Jun 30, 2024 | 30.51% |
| Mar 31, 2024 | 41.42% |
| Dec 31, 2023 | 78.49% |
| Sep 30, 2023 | 12.39% |
| Jun 30, 2023 | 42.74% |
| Mar 31, 2023 | 15.82% |
| Dec 31, 2022 | 58.35% |
| Sep 30, 2022 | 45.52% |
| Jun 30, 2022 | 17.32% |
| Mar 31, 2022 | -21.06% |
| Dec 31, 2021 | -15.45% |
| Sep 30, 2021 | -12.73% |